SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (3323)4/3/2001 4:28:41 PM
From: dalroi  Respond to of 52153
 
Peter,

what exactly is your definition of a fire sale
i used to jump in when stock were down 15-20%

but nowadays that seems to be "normal"
eg mlnm today 28-23
sheeeeeeees

anyway FWIW

nibling at near cash bios with naked puts
acla (put july almost 1$ sheeees)
lexg at 5.5 with 4.2$ cash ?
incy naked put at 10$

cheers

Stefaan

ps tomorrow is the 3drop day in line bargainday ?



To: Biomaven who wrote (3323)4/3/2001 5:11:11 PM
From: Jibacoa  Read Replies (1) | Respond to of 52153
 
NOVN's drop yesterday apparently was on the news of the results of a preliminary analysis of Phase III clinical study data for its transdermal methylphenidate system, which suggested that a supplemental clinical study will be required to support the filing of a New Drug Application (NDA).

It rallied yesterday from the 16 3/4 level and also earlier today, but it was held unchanged at 19.

I am aware that they have positive earnings and those were better in the last reported Q, the PE at 23 is not that high by "recent standards" and their HRT and deal with Novartis also look good, but do they have any potentially "block-buster" product on their pipe line?

Bernard